首页> 外文期刊>JAMA: the Journal of the American Medical Association >Glucose metabolism and coronary heart disease in patients with normal glucose tolerance.
【24h】

Glucose metabolism and coronary heart disease in patients with normal glucose tolerance.

机译:葡萄糖耐量正常的患者的糖代谢和冠心病。

获取原文
获取原文并翻译 | 示例
       

摘要

CONTEXT: Several investigations as well as prospective studies have shown a significant correlation between glucose metabolism and atherosclerosis in patients without diabetes, but differences in parameters of glucose metabolism among the various degrees of coronary disease in such patients have not been specifically evaluated. OBJECTIVE: To investigate glucose metabolism in patients with normal glucose tolerance (NGT) and coronary heart disease (CHD). DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of 234 men (mean [SD] age, 56.2 [6.1] years) with NGT and suspected CHD who were admitted from January 1 through June 30, 2001, to an academic medical center in Italy for coronary angiography. MAIN OUTCOME MEASURES: Correlation of glucose metabolic factors and extent of atherosclerosis determined by coronary angiography. Factors included levels of fasting and postload glucose and insulin, glycosylated hemoglobin (HbA1c), and lipids, as well as insulin resistance measured by homeostasis model assessment (HOMA-IR). RESULTS: Patients were divided into 4 groups based on coronary angiography: no significant stenosis (n = 42), 1-vessel disease (n = 72), 2-vessel disease (n = 64), and 3-vessel disease (n = 56). Simple correlation analysis showed that the factors correlated with the extent of atherosclerosis were levels of postload glucose (r = 0.667), HbA1c (r = 0.561), postload insulin (r = 0.221), and fasting insulin (r = 0.297), as well as HOMA-IR (r = 0.278) (P<.001 for all). Multiple stepwise regression analysis suggested that the factors independently associated with the number of stenosed coronary arteries were levels of postload plasma glucose (r = 0.572), HbA1c (r = 0.413), postload insulin (r = 0.267), and fasting insulin (r = 0.174), as well as HOMA-IR (r = 0.250) (P<.001 for all). Similar results were obtained after grouping patients by Duke Myocardial Jeopardy Score. CONCLUSIONS: For patients with NGT and different extents of atherosclerotic disease, postload glycemia and HbA1c level are not equally distributed but are significantly higher in those with more severe disease. This suggests that the glycemic milieu correlates with the cardiovascular risk according to a linear model.
机译:上下文:多项研究和前瞻性研究表明,无糖尿病患者的糖代谢与动脉粥样硬化之间存在显着相关性,但尚未明确评估这类患者不同程度冠心病之间糖代谢参数的差异。目的:研究糖耐量正常(NGT)和冠心病(CHD)患者的糖代谢。设计,地点和参与者:2001年1月1日至6月30日收治的234名NGT和疑似冠心病的男性(平均[SD]年龄,56.2 [6.1]岁)的横断面研究。意大利用于冠状动脉造影。主要观察指标:通过冠状动脉造影确定葡萄糖代谢因子与动脉粥样硬化程度的相关性。因素包括空腹和后负荷葡萄糖和胰岛素,糖基化血红蛋白(HbA1c)和脂质的水平,以及通过稳态模型评估(HOMA-IR)测量的胰岛素抵抗。结果:根据冠状动脉造影将患者分为4组:无明显狭窄(n = 42),1血管疾病(n = 72),2血管疾病(n = 64)和3血管疾病(n = 56)。简单的相关分析表明,与动脉粥样硬化程度相关的因素还有负荷后葡萄糖水平(r = 0.667),HbA1c(r = 0.561),负荷后胰岛素(r = 0.221)和空腹胰岛素(r = 0.297)。作为HOMA-IR(r = 0.278)(全部P <.001)。多元逐步回归分析表明,与狭窄冠状动脉数量独立相关的因素是负荷后血浆葡萄糖水平(r = 0.572),HbA1c(r = 0.413),负荷后胰岛素(r = 0.267)和空腹胰岛素(r = 0.174),以及HOMA-IR(r = 0.250)(所有P <.001)。根据杜克心肌危险评分对患者进行分组后,获得了相似的结果。结论:对于NGT和不同程度的动脉粥样硬化疾病患者,负荷后血糖和HbA1c水平分布不均,但在疾病较严重的患者中明显更高。这表明根据线性模型,血糖环境与心血管疾病风险相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号